| Neoadjuvant Taxotere (NCT00206505) | Baylor Breast Care Center | 1999-01-01 |
| Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer (NCT00005587) | Medical Research Council | 1999-01-01 |
| Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer (NCT00005079) | Jonsson Comprehensive Cancer Center | 1999-01-01 |
| Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer (NCT00004013) | Fred Hutchinson Cancer Center | 1999-01-01 |
| Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer (NCT00005588) | Medical Research Council | 1999-01-01 |
| Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors (NCT00003690) | Mayo Clinic | 1998-12-01 |
| Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy (NCT00003600) | Alliance for Clinical Trials in Oncology | 1998-12-01 |
| Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation (NCT00575744) | University of Arkansas | 1998-12-01 |
| Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer (NCT00003674) | Alliance for Clinical Trials in Oncology | 1998-12-01 |
| Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer (NCT00003730) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-12-01 |
| Raloxifene in Preventing Breast Cancer in Premenopausal Women (NCT00019500) | National Cancer Institute (NCI) | 1998-12-01 |
| Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer (NCT00006110) | UNC Lineberger Comprehensive Cancer Center | 1998-12-01 |
| Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer (NCT00005821) | Royal Marsden NHS Foundation Trust | 1998-12-01 |
| Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior (NCT01000883) | UNC Lineberger Comprehensive Cancer Center | 1998-12-01 |
| Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer (NCT00003680) | Scottish Cancer Therapy Network | 1998-11-01 |
| Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer (NCT00004175) | Northwestern University | 1998-11-01 |
| Combination Chemotherapy in Treating Women With Breast Cancer (NCT00003679) | Scottish Cancer Therapy Network | 1998-11-01 |
| A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer (NCT00241449) | AstraZeneca | 1998-11-01 |
| Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer (NCT00766454) | Wake Forest University Health Sciences | 1998-11-01 |
| Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients (NCT00001837) | National Institutes of Health Clinical Center (CC) | 1998-11-01 |
| Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer (NCT00004237) | Royal Marsden NHS Foundation Trust | 1998-10-01 |
| Bexarotene in Treating Patients With Metastatic Breast Cancer (NCT00003752) | Ligand Pharmaceuticals | 1998-10-01 |
| Brown Seaweed as a Breast Cancer Preventive (NCT01204957) | University of South Carolina | 1998-10-01 |
| Docetaxel in Treating Patients With Solid Tumors (NCT00003565) | Alliance for Clinical Trials in Oncology | 1998-09-01 |
| Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer (NCT00003877) | Roswell Park Cancer Institute | 1998-09-01 |
| Chemotherapy in Treating Patients With Breast Cancer (NCT00012129) | NYU Langone Health | 1998-09-01 |
| Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer (NCT00006104) | Vanderbilt-Ingram Cancer Center | 1998-09-01 |
| Letrozole After Tamoxifen in Treating Women With Breast Cancer (NCT00003140) | NCIC Clinical Trials Group | 1998-08-24 |
| Combination Chemotherapy in Treating Women With Breast Cancer (NCT00003519) | Eastern Cooperative Oncology Group | 1998-08-20 |
| Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation (NCT00003887) | Fred Hutchinson Cancer Center | 1998-08-01 |
| Biomarkers in Native American Women With Breast Cancer (NCT00898976) | Alliance for Clinical Trials in Oncology | 1998-08-01 |
| Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer (NCT00003351) | Alliance for Clinical Trials in Oncology | 1998-08-01 |
| Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer (NCT00003236) | Eastern Cooperative Oncology Group | 1998-07-13 |
| Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer (NCT00003893) | University Hospital Birmingham | 1998-07-01 |
| S9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast Cancer (NCT00031772) | SWOG Cancer Research Network | 1998-07-01 |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer (NCT00003972) | Fred Hutchinson Cancer Center | 1998-07-01 |
| Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing (NCT00165152) | Dana-Farber Cancer Institute | 1998-07-01 |
| Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer (NCT00005649) | Hoffmann-La Roche | 1998-07-01 |
| Metabolomics and Breast Cancer Risk in a Nested Case-control Study of the Cancer Prevention Study-II Nutrition Cohort (NCT03282812) | American Cancer Society, Inc. | 1998-06-01 |
| Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer (NCT00003352) | NSABP Foundation Inc | 1998-06-01 |
| ATAC - Pharmacokinetics (PK) Sub-Protocol (NCT00784862) | AstraZeneca | 1998-06-01 |
| Immunotherapy in Treating Patients With Metastatic Breast Cancer (NCT00003432) | Duke University | 1998-06-01 |
| Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel (NCT00003540) | Memorial Sloan Kettering Cancer Center | 1998-06-01 |
| Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation (NCT00003412) | Beth Israel Deaconess Medical Center | 1998-06-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors (NCT00019435) | National Cancer Institute (NCI) | 1998-05-01 |
| Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer (NCT00003219) | University of Wisconsin, Madison | 1998-05-01 |
| Temozolomide in Treating Women With Advanced Breast Cancer (NCT00005054) | The Christie NHS Foundation Trust | 1998-05-01 |
| Early Detection of Breast Cancer and Cervical Cancer in Women in India (NCT00632047) | Tata Memorial Hospital | 1998-05-01 |
| MRI to Detect Breast Tumors in Women (NCT00003302) | Abramson Cancer Center at Penn Medicine | 1998-05-01 |
| Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer (NCT00004085) | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 1998-05-01 |
| Hormone Therapy in Treating Women With Breast Cancer (NCT00003428) | Memorial Sloan Kettering Cancer Center | 1998-05-01 |
| Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer (NCT00003329) | Eastern Cooperative Oncology Group | 1998-04-07 |
| S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer (NCT00005975) | SWOG Cancer Research Network | 1998-04-01 |
| Bryostatin 1 in Treating Patients With Stage IV Breast Cancer (NCT00003205) | University of Colorado, Denver | 1998-04-01 |
| Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer (NCT00003539) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer (NCT00003408) | Cancer Treatment Centers of America | 1998-04-01 |
| Maintenance Chemotherapy in Metastatic Breast Cancer (NCT00289263) | MANTA 1 Study Italian Collaborative Group | 1998-04-01 |
| Continuation of Follow-up of DES-Exposed Cohorts (NCT00340600) | National Cancer Institute (NCI) | 1998-03-18 |
| ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years (NCT00286117) | AstraZeneca | 1998-03-01 |
| Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer (NCT00004205) | ETOP IBCSG Partners Foundation | 1998-03-01 |
| Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00003269) | Scripps Health | 1998-02-01 |
| Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer (NCT00003162) | Radiation Therapy Oncology Group | 1998-02-01 |
| Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer (NCT00003418) | International Collaborative Cancer Group | 1998-02-01 |
| Impact of Radiotherapy on Survival in Breast Cancer Patients (NCT07631962) | Motamed Cancer Institute | 1998-01-01 |
| Imaging Characteristics of Breast Cancer in Women Under 40 Years of Age (NCT00155038) | National Taiwan University Hospital | 1998-01-01 |
| Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors (NCT00003125) | Georgetown University | 1998-01-01 |
| Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease (NCT00003357) | Memorial Sloan Kettering Cancer Center | 1998-01-01 |
| Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer (NCT00429572) | M.D. Anderson Cancer Center | 1998-01-01 |
| Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer (NCT00006368) | Novartis Pharmaceuticals | 1998-01-01 |
| Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast (NCT00003404) | Dartmouth-Hitchcock Medical Center | 1998-01-01 |
| Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy (NCT00003010) | Eastern Cooperative Oncology Group | 1997-12-02 |
| Menstrual Cycle Maintenance and Quality of Life: A Prospective Study (NCT00589654) | Memorial Sloan Kettering Cancer Center | 1997-12-01 |
| Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer (NCT00004207) | University of Leicester | 1997-12-01 |
| Doxorubicin in Treating Women With Advanced Breast Cancer (NCT00003165) | University of Glasgow | 1997-12-01 |
| Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect (NCT00003425) | University of Kentucky | 1997-12-01 |
| Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer (NCT00003135) | The University of Texas Health Science Center, Houston | 1997-11-01 |
| Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009) (NCT01031030) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 1997-11-01 |
| S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer (NCT00003095) | SWOG Cancer Research Network | 1997-11-01 |
| Axillary Drainage Following Lymph Node Dissection in Women With Stage I or Stage II Breast Cancer (NCT00005600) | Royal Marsden NHS Foundation Trust | 1997-11-01 |
| Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors (NCT00003038) | Mayo Clinic | 1997-10-01 |
| Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors (NCT00003107) | Indiana University | 1997-10-01 |
| Corellation of Mutations, TILs and Age in Breast Cancer (NCT04033965) | Hellenic Cooperative Oncology Group | 1997-09-03 |
| Combination Chemotherapy in Treating Patients With Breast Cancer (NCT00003088) | Alliance for Clinical Trials in Oncology | 1997-09-01 |
| Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer (NCT00003771) | Regional Oncologic Center | 1997-09-01 |
| Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer (NCT00003654) | UNICANCER | 1997-09-01 |
| High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer (NCT00003392) | UNC Lineberger Comprehensive Cancer Center | 1997-09-01 |
| Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer (NCT00005991) | M.D. Anderson Cancer Center | 1997-08-25 |
| Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer (NCT00002826) | Eastern Cooperative Oncology Group | 1997-08-14 |
| Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer (NCT00002998) | Alliance for Clinical Trials in Oncology | 1997-08-01 |
| Chemotherapy in Treating Patients With Solid Tumors (NCT00003103) | Memorial Sloan Kettering Cancer Center | 1997-08-01 |
| Diet and Estrogen Metabolism in Postmenopausal Women (NCT00003098) | Jonsson Comprehensive Cancer Center | 1997-08-01 |
| Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer (NCT00010140) | International Collaborative Cancer Group | 1997-08-01 |
| Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer (NCT00005058) | Royal Marsden NHS Foundation Trust | 1997-08-01 |
| Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer (NCT00003253) | Oncotech | 1997-07-01 |
| Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer (NCT00003041) | Ohio State University Comprehensive Cancer Center | 1997-07-01 |
| Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ (NCT00002934) | Eastern Cooperative Oncology Group | 1997-06-25 |
| Docetaxel in Node Positive Adjuvant Breast Cancer (NCT00688740) | Sanofi | 1997-06-01 |
| High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer (NCT00003068) | University of Arizona | 1997-06-01 |
| ATAC - Endometrial Sub-Protocol (NCT00814125) | AstraZeneca | 1997-06-01 |
| Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer (NCT00007891) | Cancer Research Institute of Contra Costa | 1997-06-01 |